Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HBHEPB | HIB + HEP B (COMVAX) | MERCK & CO. INC. | UNK | — | — |
No additional AE; temperature excursion and reports that a dose of PEDVAX HIB was administered; This spontaneous report was received from an Other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 24-Sep-2025, the patient was vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB), (lot # and expiration date were not reported) for prophylaxis. The temperature excursion vaccine's temperature was 11.1 degree and time frame was 168 hours (product storage error). No additional adverse event (no adverse event). Lot # is being requested and will be submitted if received.